Clinical Performance of HISTOACRYL® LAPFIX - CANNULA for Laparoscopic Inguinal Hernia Repair (HISTOLAP)

Aesculap

Status: Enrolling

Conditions: Inguinal Hernia

Treatments: Device: hernia repair surgery

Study type: Observational

Funder types: Industry

Identifiers

NCT06298500

AAG-O-H-2115

Details and patient eligibility

About

The goal of this retrospective study is to identify the incidence of hernia recurrence following the application of Histoacryl® Lapfix - Cannula for laparoscopic mesh fixation in patients undergoing hernia repair surgery. All adult patients who underwent laparoscopic inguinal hernia repair with Histoacryl® Lapfix - Cannula in the period June 2018 - March 2021 at Hospital San Juan de Dios will be analysed. The investigator team will access electronical medical records for the cohort of patients identified.

Enrollment: 448 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients (≥18 years old)
• treated between June 2018 and March 2021 at the Hospital San Juan de Dios for laparoscopic mesh fixation with Histoacryl Lapfix - Cannula after inguinal hernia repair surgery.

Exclusion criteria

• No exclusion criteria has been set.

Trial design

448 participants in 1 patient group

Histoacryl Lapfix

Description:

Histoacryl Lapfix - Cannula for laparoscopic mesh fixation in patients undergoing hernia repair surgery

Treatment:

Device: hernia repair surgery